Page 550 - Cote clinical veterinary advisor dogs and cats 4th
P. 550

Dermatomyositis  246.e3





  VetBooks.ir                                                                                                         Diseases and   Disorders

















           DERMATOMYOSITIS  Skin biopsy from dog with dermatomyositis. Note clefting   DERMATOMYOSITIS  Classic alopecic tail tip of dogs with dermatomyositis.
           and small hair follicles.
























           DERMATOMYOSITIS  Adult dog with severe disease. Facial lesions are strongly   DERMATOMYOSITIS  A 6-month-old Shetland sheepdog showing facial lesions.
           compatible with other immune-mediated skin diseases (e.g., lupus).



           Initial Database                    •  Muscle biopsy from temporal muscles reveals   •  Acute exacerbations
           •  Skin  cytologic  preparations  to  rule  out   myofibrillar degeneration and atrophy, with   ○   Prednisone  1-2 mg/kg  PO  q  12-24h,
             pyoderma and/or Malassezia overgrowth  accumulations of mixed inflammatory cells.  weaning down to an alternate-day regimen
           •  Skin scrapings and hair trichograms to rule   •  Neurologic examination is usually normal.  based on a favorable response
             out demodicosis (p. 1091)         •  Elevated concentrations of immunoglobulin   ○   Use  prednisone  in  conjunction  with
           •  Wood’s lamp and dermatophyte culture to   G (IgG) and circulating immune complexes   pentoxifylline 15-25 mg/kg PO q 8-12h
             rule out dermatophytosis           may be seen.                          for severe acute exacerbations.
           •  Serum  biochemistry  profile  may  show                               ○   Focal lesions can be treated with topical
             elevated creatine kinase; CBC and urinalysis    TREATMENT                0.1% tacrolimus.
             results unremarkable
                                               Treatment Overview                 Chronic Treatment
           Advanced or Confirmatory Testing    This  disease  can  be  managed  but  not   •  Chronic management
           •  Skin biopsy for histopathologic evaluation   cured.  The  primary  goal  is  to  minimize   ○   Minimize exacerbations by avoidance of
             (may be nondiagnostic in mild cases).   scarring of facial skin and prevent/manage    sunlight.
             Characteristic hydropic degeneration in the   debilitating  myositis.  No  controlled  studies   ○   Omega-3  essential  fatty  acids  and/or
             basal cell layer, with a mild perivascular to   exist to support that one treatment approach   vitamin  E  400-800 IU/dose  PO  q  24h
             interstitial dermatitis. Follicular atrophy   is superior to another.    may  be  helpful,  but  it  may  take  >  3
             may be noted in chronic lesions. Vasculitis                              months to see benefit.
             is occasionally noted.            Acute General Treatment              ○   Pentoxifylline 15-25 mg/kg PO q 8-12h
           •  Electromyograms  are  abnormal  in  cases   •  Lesions  wax  and  wane,  and  response  to   alone; may take  >3  months  to  see
             with subclinical or clinical myositis and   therapy is difficult to evaluate.  improvement.
             show positive sharp waves and fibrillation   •  Therapy  is  based  on  stage  of  the  disease:   ○   Cyclosporine (Atopica, Neoral) 5 mg/kg
             potentials in muscles of the head and distal   treatment of acute exacerbations or chronic   PO q 12-24h as long-term therapy in place
             extremities.                       management                            of glucocorticoids

                                                      www.ExpertConsult.com
   545   546   547   548   549   550   551   552   553   554   555